F. Artosi, “Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series”, Dermatol Pract Concept, vol. 15, no. 4, p. 5570, Oct. 2025, doi: 10.5826/dpc.1504a5570.